Keywordsbiglycan; carbohydrate sulfotransferase 14; decorin; chondroitin sulfate; dermatan sulfate; dermatan sulfate epimerase; dermatan 4-O-sulfotransferase; Ehlers-Danlos syndrome; glycosaminoglycan; proteoglycan; spondyloepimetaphyseal dysplasia.; glycocalyx; endothelial cell; dysfunction; selectin; dermatan sulfate; deep vein thrombosis; glycosaminoglycans; glucosamine sulfate; arthritis; arthroses; nuclear magnetic resonance; glycosaminoglycan; heparin; cell penetrating peptide; octaarginine; non-endocytic membrane translocation; in-cell nuclear magnetic resonance spectroscopy; dengue virus; DC-SIGN; envelope protein; flavivirus; flavivirus inhibitors; glycosaminoglycans; Japanese encephalitis virus; proteoglycans; viral infection; West Nile virus; yellow fever virus; Zika virus; glycosaminoglycans; heparin; heparan sulfate; cartilage; mesenchymal stem cells; tissue engineering; growth factors; growth differentiation factor 5; GDF5; heparin; protamine sulfate; neutralization; enoxaparin; USP; MW determination; oligosaccharide calibrants; computational modeling; HPLC; compendial test; chemokines; glycosaminoglycans/GAGs; heparan sulfate; chemokine therapeutics; chemokine structure; chemokine oligomerization; heparin mimetics; heparin; heparan sulfate; glycosaminoglycan; anticoagulant; cancer; anti-inflammatory; chondroitin sulfate; decorin; dermatan sulfate; glycosaminoglycans; glypican; heparan sulfate; heparin; hyaluronan; keratan sulfate; perlecan; proteoglycans; serglycin; syndecan
